Lymphoma Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
61%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 61 cents are available for programs.
My anchor
OVERVIEW
About Lymphoma Canada:
Lymphoma Canada is a three-star charity that is financially transparent. It has an average results reporting grade and overhead costs outside of Ci's reasonable range for overhead spending.
Lymphoma Canada (LC) was founded in 2000 through the merger between two lymphoma foundations, both of which were founded in 1998. Lymphoma Canada supports those affected by lymphoma with the goal of life unlimited by lymphoma. The charity states among cancers in Canada, lymphoma is the fifth most common. It also states that awareness among Canadians about lymphoma is low. LC runs four main programs: Patient Education, Patient Support, Research, and Advocacy. Charity Intelligence calculates it spent $479k on its programs and grants in 2023.
The Patient Education program received 50% of program spending. LC provides lymphoma patients and caregivers with educational resources, webinars, and conferences. The charity hosted 14 lymphoma webinars in 2023. The charity reports that almost 2,000 people attended the webinars. LC reports it gave out over 6,000 free patient resource materials in 2023. It hosted a National Conference and a French Conference on blood cancer in 2023.
The Patient Support program received 31% of program spending. The charity’s Peer-to-Peer mentorship program connects patients and caregivers to someone who has had a similar experience. It also offers online support programs in collaboration with Wellspring Cancer Support. The virtual groups run on the first Wednesday of every month.
The Research program received 14% of program spending. LC grants money to help advance lymphoma treatment and quality of life research. The charity provided a $50k grant to two research groups in 2023. One group is studying treatment delivery and patient outcomes. The other group is studying the interplay between cancer cells and their surrounding environment.
The Advocacy program received 6% of program spending. LC advocated via an open letter for timely reimbursement, approval, and increased access to CAR-T. In 2023 LC released a new guide to awareness of rising lymphoma incidence and mortality rates in Canada. The guide also provides an algorithm for easier lymphoma diagnosis.
My anchor
Results and Impact
In the second half of 2022, Lymphoma Canada and a group of Canadian clinical experts came together. They updated and developed the Canadian guidelines for the frontline and relapsed/refractory treatment of Chronic Lymphocytic Leukemia. At the start of 2023, these articles were published in the Leukemia Research journal.
While Ci highlights these key results, they may not be a complete representation of Lymphoma Canada’s results and impact.
The charity is not yet rated on impact (n/r).
My anchor
Finances
In 2023 Lymphoma Canada received $1.0m in cash donations. Administrative costs are 17% of revenues (excluding investment income). Fundraising costs are 22% of donations. This results in total overhead spending of 39%. For every dollar donated, 61 cents are available to go to the cause. This falls outside Ci’s reasonable range for overhead spending.
In 2023 LC spent $479k on its programs and grants, which is 44% of its revenue. In 2023 it had a surplus of $196k.
Lymphoma Canada has $1.6m in reserve funds. This can cover 336%, or three years and four months of its annual program spending. Its cash balance increased by 103% from 2020 to 2023 ($691k to $1.4m).
This charity report is an update that has been sent for review to Lymphoma Canada. Changes and edits may be forthcoming.
Updated on July 18, 2024, by Grady Simpson.
Financial Review
Fiscal year ending December
|
2023 | 2022 | 2021 |
|---|---|---|---|
| Administrative costs as % of revenues | 17.3% | 15.8% | 11.8% |
| Fundraising costs as % of donations | 21.8% | 17.9% | 15.3% |
| Total overhead spending | 39.0% | 33.7% | 27.0% |
| Program cost coverage (%) | 336.4% | 349.6% | 265.2% |
Summary Financial StatementsAll figures in $s |
2023 | 2022 | 2021 |
|---|---|---|---|
| Donations | 1,043,569 | 1,151,609 | 1,116,821 |
| Government funding | 4,822 | 4,641 | 71,834 |
| Other income | 45,939 | 14,083 | 1,931 |
| Total revenues | 1,094,330 | 1,170,333 | 1,190,586 |
| Program costs | 429,308 | 386,204 | 410,953 |
| Grants | 50,000 | 50,000 | 50,000 |
| Administrative costs | 188,759 | 185,016 | 140,162 |
| Fundraising costs | 226,977 | 206,500 | 170,565 |
| Other costs | 3,170 | 3,195 | 2,791 |
| Total spending | 898,214 | 830,915 | 774,471 |
| Cash flow from operations | 196,116 | 339,418 | 416,115 |
| Capital spending | 0 | 0 | 0 |
| Funding reserves | 1,612,471 | 1,524,838 | 1,222,314 |
Note: DEFERRED ADJUSTMENT: LC uses deferred accounting. To show donors information on a consistent basis, Ci adjusted for these deferred revenues. This affected revenues by ($41k) in 2023, ($43k) in 2022, and $70k in 2021.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
1 |
$160k - $200k |
0 |
$120k - $160k |
0 |
$80k - $120k |
0 |
$40k - $80k |
2 |
< $40k |
4 |
Information from most recent CRA Charities Directorate filings for F2022
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: (905) 858-5967